Fenretinide: a prototype cancer prevention drug

Author： Malone Winfred Perloff Marjorie Crowell James Sigman Caroline Higley Howard

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.11, 2003-11, pp. : 1829-1842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemoprevention of Breast Cancer with Fenretinide

By Torrisi R.

Drugs, Vol. 61, Iss. 7, 2001-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

A Prevention Strategy for Circumventing Drug Resistance in Cancer Chemotherapy

Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. : 1595-1614

Bentham Science Publishers

Access to resources Recommend Favorite

Transport of a novel anti-cancer agent, fenretinide across Caco-2 monolayers

By Kokate Amit Li Xiaoling Jasti Bhaskara

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 197-203

Springer Publishing Company

Access to resources Recommend Favorite

Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer

Current Drug Targets, Vol. 1, Iss. 2, 2000-09 ,pp. : 163-183

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Design, Organic Synthesis, and Biological Evaluation of Polyphenol Proteasome Inhibitors: Significance in Drug Discovery and Cancer Prevention

Drug Design Reviews - Online, Vol. 2, Iss. 3, 2005-05 ,pp. : 227-232

Bentham Science Publishers

Access to resources Recommend Favorite